[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Cancer Registry Software Market By Type (Integrated and Standalone) By Deployment Type (On-premise and Cloud-based) By Component (Commercial and Public) By End User (Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers) By Country, Industry Analysis and Forecast, 2019 - 2025

February 2020 | 85 pages | ID: E6DA41D93DABEN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe Cancer Registry Software Market would witness market growth of 9.85% CAGR during the forecast period (2019-2025).

Cancer is a significant national responsibility. Cancer is the second leading cause of mortality in the United States. Every year, cancer-cost is one of the largest costs in Healthcare spending and loss of productivity due to illness and death. Reducing the cancer burden of the country is a great and noble cause involving many people, such as researchers, physicians, epidemiologists, public health planners, medical students, legislators, and others. In Europe, cancer registration is hindered by substantial differences in the consistency and scope of CRs, by inadequate harmonization and comparability of procedures and data, by heterogeneous legislation that restricts CR's ability to network, cooperate and engage in research. They arise against the backdrop of large variations in national economic, legislative, social and cultural contexts.

Important measures have been taken at the level of the European Union (EU) in recent years to map out and understand these problems, to identify best practices and to formulate sound recommendations, and also to develop policy mechanisms and tools for cooperation and information sharing. However, since cancer has now become Europe's second-largest cause of death, one-third of the population still lacks reliable cancer identification, mostly in low-resource and health-status regions. It is therefore important that efforts to support the advancement of CRs continue and that the wealth of expertise and vision gained in this field is transformed into practice.

Based on Type, the market is segmented into Integrated and Standalone. Based on Deployment Type, the market is segmented into On-premise and Cloud-based. Based on Component, the market is segmented into Commercial and Public. Based on End User, the market is segmented into Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.

Scope of the Study

Market Segmentation:

By Type
  • Integrated
  • Standalone
By Deployment Type
  • On-premise
  • Cloud-based
By Component
  • Commercial
  • Public
By End User
  • Government & Third party
  • Research Centers
  • Hospital & Medical Centers
  • Private Payers
  • Pharma Biotech & Medical Device Suppliers
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • IBM Corporation
  • McKesson Corporation
  • Conduent, Incorporated
  • Elekta AB
  • Ordinal Data, Inc.
  • Onco, Inc.
  • C/Net Solutions
  • Rocky Mountain Cancer Data System
  • Electronic Registry System, Inc.
  • Himagine Solutions, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Europe Cancer Registry Software Market, by Type
  1.4.2 Europe Cancer Registry Software Market, by Deployment Type
  1.4.3 Europe Cancer Registry Software Market, by Component
  1.4.4 Europe Cancer Registry Software Market, by End User
  1.4.5 Europe Cancer Registry Software Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Executive Summary
  2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. EUROPE CANCER REGISTRY SOFTWARE MARKET BY TYPE

3.1 Europe Integrated Cancer Registry Software Market by Country
3.2 Europe Standalone Cancer Registry Software Market by Country

CHAPTER 4. EUROPE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL

4.1 Europe On-premise Cancer Registry Software Market by Country
4.2 Europe Cloud-based Cancer Registry Software Market by Country

CHAPTER 5. EUROPE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT

5.1 Europe Commercial Cancer Registry Software Market by Country
5.2 Europe Public Cancer Registry Software Market by Country

CHAPTER 6. EUROPE CANCER REGISTRY SOFTWARE MARKET BY END USER

6.1 Europe Government & Third party Market by Country
6.2 Europe Research Centers Market by Country
6.3 Europe Hospital & Medical Centers Market by Country
6.4 Europe Private Payers Market by Country
6.5 Europe Pharma biotech & medical device suppliers Market by Country

CHAPTER 7. EUROPE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY

7.1 Germany Cancer Registry Software Market
  7.1.1 Germany Cancer Registry Software Market by Type
  7.1.2 Germany Cancer Registry Software Market by Deployment Model
  7.1.3 Germany Cancer Registry Software Market by Component
  7.1.4 Germany Cancer Registry Software Market by End User
7.2 UK Cancer Registry Software Market
  7.2.1 UK Cancer Registry Software Market by Type
  7.2.2 UK Cancer Registry Software Market by Deployment Model
  7.2.3 UK Cancer Registry Software Market by Component
  7.2.4 UK Cancer Registry Software Market by End User
7.3 France Cancer Registry Software Market
  7.3.1 France Cancer Registry Software Market by Type
  7.3.2 France Cancer Registry Software Market by Deployment Model
  7.3.3 France Cancer Registry Software Market by Component
  7.3.4 France Cancer Registry Software Market by End User
7.4 Russia Cancer Registry Software Market
  7.4.1 Russia Cancer Registry Software Market by Type
  7.4.2 Russia Cancer Registry Software Market by Deployment Model
  7.4.3 Russia Cancer Registry Software Market by Component
  7.4.4 Russia Cancer Registry Software Market by End User
7.5 Spain Cancer Registry Software Market
  7.5.1 Spain Cancer Registry Software Market by Type
  7.5.2 Spain Cancer Registry Software Market by Deployment Model
  7.5.3 Spain Cancer Registry Software Market by Component
  7.5.4 Spain Cancer Registry Software Market by End User
7.6 Italy Cancer Registry Software Market
  7.6.1 Italy Cancer Registry Software Market by Type
  7.6.2 Italy Cancer Registry Software Market by Deployment Model
  7.6.3 Italy Cancer Registry Software Market by Component
  7.6.4 Italy Cancer Registry Software Market by End User
7.7 Rest of Europe Cancer Registry Software Market
  7.7.1 Rest of Europe Cancer Registry Software Market by Type
  7.7.2 Rest of Europe Cancer Registry Software Market by Deployment Model
  7.7.3 Rest of Europe Cancer Registry Software Market by Component
  7.7.4 Rest of Europe Cancer Registry Software Market by End User

CHAPTER 8. COMPANY PROFILES

8.1 IBM Corporation
  8.1.1 Company Overview
  8.1.2 Financial Analysis
  8.1.3 Regional & Segmental Analysis
  8.1.4 Research & Development Expenses
  8.1.5 SWOT Analysis
8.2 McKesson Corporation
  8.2.1 Company Overview
  8.2.2 Financial Analysis
  8.2.3 Segmental and Regional Analysis
  8.2.4 Research & Development Expense
8.3 Conduent, Incorporated
  8.3.1 Company Overview
  8.3.2 Financial Analysis
  8.3.3 Research & Development Expense
  8.3.4 Recent strategies and developments:
    8.3.4.1 Product Launches and Product Expansions:
8.4 Elekta AB
  8.4.1 Company Overview
  8.4.2 Financial Analysis
  8.4.3 Regional Analysis
  8.4.4 Research & Development Expense
  8.4.5 Recent strategies and developments:
    8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Ordinal Data, Inc.
  8.5.1 Company Overview
8.6 Onco, Inc.
  8.6.1 Company Overview
8.7 C/Net Solutions
  8.7.1 Company Overview
8.8 Rocky Mountain Cancer Data System
  8.8.1 Company Overview
8.9 Electronic Registry System, Inc.
  8.9.1 Company Overview
8.1 Himagine Solutions, Inc.
  8.10.1 Company Overview

LIST OF TABLES

TABLE 1 EUROPE CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 2 EUROPE CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 3 EUROPE CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 4 EUROPE CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 5 EUROPE INTEGRATED CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 6 EUROPE INTEGRATED CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 7 EUROPE STANDALONE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 8 EUROPE STANDALONE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 9 EUROPE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 10 EUROPE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 11 EUROPE ON-PREMISE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 12 EUROPE ON-PREMISE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 13 EUROPE CLOUD-BASED CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 14 EUROPE CLOUD-BASED CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 15 EUROPE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 16 EUROPE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 17 EUROPE COMMERCIAL CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 18 EUROPE COMMERCIAL CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 19 EUROPE PUBLIC CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 20 EUROPE PUBLIC CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 21 EUROPE CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 22 EUROPE CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 23 EUROPE GOVERNMENT & THIRD PARTY MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 24 EUROPE GOVERNMENT & THIRD PARTY MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 25 EUROPE RESEARCH CENTERS MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 26 EUROPE RESEARCH CENTERS MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 27 EUROPE HOSPITAL & MEDICAL CENTERS MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 28 EUROPE HOSPITAL & MEDICAL CENTERS MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 29 EUROPE PRIVATE PAYERS MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 30 EUROPE PRIVATE PAYERS MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 31 EUROPE PHARMA BIOTECH & MEDICAL DEVICE SUPPLIERS MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 32 EUROPE PHARMA BIOTECH & MEDICAL DEVICE SUPPLIERS MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 33 EUROPE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2015 - 2018, USD THOUSANDS
TABLE 34 EUROPE CANCER REGISTRY SOFTWARE MARKET BY COUNTRY, 2019 - 2025, USD THOUSANDS
TABLE 35 GERMANY CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 36 GERMANY CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 37 GERMANY CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 38 GERMANY CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 39 GERMANY CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 40 GERMANY CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 41 GERMANY CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 42 GERMANY CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 43 GERMANY CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 44 GERMANY CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 45 UK CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 46 UK CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 47 UK CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 48 UK CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 49 UK CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 50 UK CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 51 UK CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 52 UK CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 53 UK CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 54 UK CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 55 FRANCE CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 56 FRANCE CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 57 FRANCE CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 58 FRANCE CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 59 FRANCE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 60 FRANCE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 61 FRANCE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 62 FRANCE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 63 FRANCE CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 64 FRANCE CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 65 RUSSIA CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 66 RUSSIA CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 67 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 68 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 69 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 70 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 71 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 72 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 73 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 74 RUSSIA CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 75 SPAIN CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 76 SPAIN CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 77 SPAIN CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 78 SPAIN CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 79 SPAIN CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 80 SPAIN CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 81 SPAIN CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 82 SPAIN CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 83 SPAIN CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 84 SPAIN CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 85 ITALY CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 86 ITALY CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 87 ITALY CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 88 ITALY CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 89 ITALY CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 90 ITALY CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 91 ITALY CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 92 ITALY CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 93 ITALY CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 94 ITALY CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 95 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET, 2015 - 2018, USD THOUSANDS
TABLE 96 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET, 2019 - 2025, USD THOUSANDS
TABLE 97 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2015 - 2018, USD THOUSANDS
TABLE 98 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY TYPE, 2019 - 2025, USD THOUSANDS
TABLE 99 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2015 - 2018, USD THOUSANDS
TABLE 100 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY DEPLOYMENT MODEL, 2019 - 2025, USD THOUSANDS
TABLE 101 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2015 - 2018, USD THOUSANDS
TABLE 102 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY COMPONENT, 2019 - 2025, USD THOUSANDS
TABLE 103 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY END USER, 2015 - 2018, USD THOUSANDS
TABLE 104 REST OF EUROPE CANCER REGISTRY SOFTWARE MARKET BY END USER, 2019 - 2025, USD THOUSANDS
TABLE 105 KEY INFORMATION – IBM CORPORATION
TABLE 106 KEY INFORMATION – MCKESSON CORPORATION
TABLE 107 KEY INFORMATION –CONDUENT, INCORPORATED
TABLE 108 KEY INFORMATION – ELEKTA AB
TABLE 109 KEY INFORMATION – ORDINAL DATA, INC.
TABLE 110 KEY INFORMATION – ONCO, INC.
TABLE 111 KEY INFORMATION – C/NET SOLUTIONS
TABLE 112 KEY INFORMATION – ROCKY MOUNTAIN CANCER DATA SYSTEM
TABLE 113 KEY INFORMATION – ELECTRONIC REGISTRY SYSTEM, INC.
TABLE 114 KEY INFORMATION –HIMAGINE SOLUTIONS, INC.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 SWOT ANALYSIS: IBM CORPORATION


More Publications